The efficacy of nonpharmacological treatment for dementia-related apathy

Alzheimer Disease and Associated Disorders

Volumn 25, Issue 3, 2011, Pages 213-219

  Ferrero Arias, Julio ^a   Goñi Imízcoz, Miguel ^b   González Bernal, Jerónimo ^c   Lara Ortega, Fernando ^c   Da Silva González, Álvaro ^d   Díez Lopez, Mateo ^e  

^a Clínica La Milagrosa   (United States)

^b HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^c UNIVERSITY OF BURGOS   (Spain)

^d Medical Services of Nursing Home   (Spain)

^e Centro Residencial Jardin de Tardajos   (Spain)

Author keywords

controlled clinical trial; dementia related apathy; nonpharmacological treatment

Indexed keywords

ADULT; AGED; APATHETIC DEMENTIA; APATHY; ART THERAPY; ARTICLE; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DANCING; DAY CARE; DEMENTIA; DEMENTIA APATHY INTERVIEW AND RATING SCALE; EXERCISE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; MUSIC THERAPY; NEUROPSYCHIATRIC INVENTORY QUESTIONNAIRE; NEUROPSYCHIATRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGING; SINGLE BLIND PROCEDURE; SPEECH;

AGED; AGED, 80 AND OVER; APATHY; CROSS-OVER STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OCCUPATIONAL THERAPY; SINGLE-BLIND METHOD;

EID: 80052266442     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3182087dbc     Document Type: Article

References (48)

1. Starkstein SE, Ingram L, Garau ML, et al. On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry. 2005;76:1070-1074. (Pubitemid 41081277)
2. Starkstein SE, Petracca G, Chemerinski E, et al. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry. 2001;158:872-877. (Pubitemid 32547615)
3. García-Alberca JM, Pablo Lara J, Gonzá lez-Baró n S, et al. Prevalencia y comorbilidad de síntomas neuropsiquiá tricos en la enfermedad de Alzheimer. Actas Esp Psiquiatr. 2008;36: 265-270.
4. Clarke DE, van Reekum R, Simard M, et al. Apathy in dementia: Clinical and sociodemographic correlates. J Neuropsychiatry Clin Neurosci. 2008;20:337-347.
5. Starkstein SE, Jorge R, Mizrahi R, et al. A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2006;77:8-11. (Pubitemid 43022682)
6. Bruen PD, McGeown WJ, Shanks MF, et al. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain. 2008;131:2455-2463.
7. Marshall GA, Fairbanks LA, Tekin S, et al. Neuropathological correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;21:144-147. (Pubitemid 43201323)
8. Apostolova LG, Akopyan GG, Partiali N, et al. Structural correlates of apathy in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;27:91-97. (Pubitemid 47094067)
9. Marshall GA, Monserratt L, Harwood D, et al. Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol. 2007;64:1015-1020. (Pubitemid 47048003)
10. David R, Koulibaly M, Benoit M, et al. Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases. A SPECT study with partial volume effect correction. Clin Neurol Neurosurg. 2008;110:19-24. (Pubitemid 350266163)
11. Lechowski L, Benoit M, Chassagne P, et al. Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: The REAL longitudinal cohort study. Int J Geriatr Psychiatry. 2009;24:341-346.
12. Turro-Garriga O, Soler-Cors O, Garre-Olmo J, et al. Distribució n factorial de la carga en cuidadores de pacientes con enfermedad de Alzheimer. Rev Neurol. 2008;46: 582-588. (Pubitemid 351767869)
13. Litvinenko IV, Odinak MM, Mogil'naya VI, et al. Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial). Neurosci Behav Physiol. 2008;38:937-945.
14. Herrmann N, Rabheru K, Wang J, et al. Galantamine treatment of problematic behavior in Alzheimer disease: Post-hoc analysis of pooled data from three large trials. Am J Geriatr Psychiatry. 2005;13:527-534.
15. Gauthier S, Feldman H, Hecker J, et al; Donepezil MSAD Study Investigators Group. Efficacy of donepezil on behavioural symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr. 2002;14:389-404. (Pubitemid 36331605)
16. Gauthier S, Juby A, Rehel B, et al. EXACT: Rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease. Int J Clin Pract. 2007;61:886-895. (Pubitemid 46744076)
17. Cummings JL, Mackell J, Kaufer D. Behavioral effects of current Alzheimer's disease treatments: A descriptive review. Alzheimers Dement. 2008;4:49-60.
18. Herrmann N, Rothenburg LS, Black SE, et al. Methylphenidate for the treatment of apathy in Alzheimer disease: Prediction of response using dextroamphetamine challenge. J Clin Psychopharmacol. 2008;28:296-301.
19. Jansen IH, Olde Rikkert MG, Hulsbos HA, et al. Toward individualized evidence-based medicine: Five "N of 1" trials of methylphenidate in geriatric patients. J Am Geriatr Soc. 2001; 49:474-476. (Pubitemid 32390884)
20. Padala PR, Burke WJ, Bhatia SC, et al. Treatment of apathy with methylphenidate. J Neuropsychiatry Clin Neurosci. 2007; 19:81-83. (Pubitemid 46294450)
21. Van Reekum R, Bayley M, Garner S, et al. N of 1 study: Amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Inj. 1995;9:49-53.
22. Marin RS, Fogel BS, Hawkins J, et al. Apathy: A treatable syndrome. J Neuropsychiatry Clin Neurosci. 1995;7:23-30.
23. Chapman SB, Weiner MF, Rackley A, et al. Effects of cognitive- communication stimulation for Alzheimer's disease patients treated with donepezil. J Speech Lang Hear Res. 2004;47:1149-1163. (Pubitemid 39492070)
24. Staal JA, Sacks A, Matheis R, et al. The effects of Snoezelen (multi-sensory behavior therapy) and psychiatric care on agitation, apathy, and activities of daily living in dementia patients on a short term geriatric psychiatric inpatient unit. Int J Psychiatry Med. 2007;37:357-370. (Pubitemid 351468860)
25. Raglio A, Bellelli G, Traficante D, et al. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheimer Dis Assoc Disord. 2008;22:158-162.
26. Holmes C, Knights A, Dean C, et al. Keep music live: Music and the alleviation of apathy in dementia subjects. Int Psychogeriatr. 2006;18:623-630. (Pubitemid 44622996)
27. Politis AM, Vozzella S, Mayer LS, et al. A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. Int J Geriatr Psychiatry. 2004;19:1087-1094. (Pubitemid 39496937)
28. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572. (Pubitemid 12124384)
29. Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology. 1993;43:2412-2414. (Pubitemid 23346995)
30. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J. 1965;14:61-65.
31. Lobo A, Ezquerra J, Gómez Burgada F, et al. El miniexamen cognoscitivo (un "test" sencillo, prá ctico, para detectar alteraciones intelectuales en pacientes médicos). Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1979;7:189-202.
32. Martínez de la Iglesia J, Onís Vilches MC, Duenas Herrero R, et al. Versió n espanola del cuestionario de Yesavage abreviado (GDS) para el cribado de depresió n en mayores de 65 anos: Adaptació n y validació n. Medifam. 2002;12:620-630.
33. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and senile change in the gray matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
34. Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233-239. (Pubitemid 30303778)
35. Strauss ME, Sperry SD. An informant-based assessment of apathy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15:176-183. (Pubitemid 35006772)
36. Landes AM, Sperry SD, Strauss ME. Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2005;17: 342-349. (Pubitemid 46179297)
37. Mega MS, Cummings JL, Fiorello T, et al. The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996;46:130-135. (Pubitemid 26156117)
38. Bozzola FG, Gorelick PB, Freels S. Personality changes in Alzheimer's disease. Arch Neurol. 1992;49:297-300.
39. Aalten P, Verhey FR, Boziki M, et al. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: Part I. Dement Geriatr Cogn Disord. 2007;24:457-463. (Pubitemid 350175906)
40. López-Pousa S, Vilalta-Franch J, Garre-Olmo J, et al. Caracterizacio ́n y prevalencia de los síntomas psicoló gicos y conductuales en pacientes con demencia. Rev Neurol. 2007;45:683-688. (Pubitemid 350292867)
41. Aalten P, Verhey FR, Boziki M, et al. Consistency of neuropsychiatric syndromes across dementias: Results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord. 2008;25:1-8. (Pubitemid 350308380)
42. Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry. 2005;76:337-341.
43. Mendez MF, Lauterbach EC, Sampson SM. ANPA Committee on Research. An evidence-based review of the psychopathology of frontotemporal dementia: A report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci. 2008;20:130-149.
44. Turró -Garriga O, Ló pez-Pousa S, Vilalta-Franch J, et al. Estudio longitudinal de la apatía en pacientes con enfermedad de Alzheimer. Rev Neurol. 2009;48:7-13.
45. Deakin JB, Rahman S, Nestor PJ, et al. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: A double-blind randomized controlled trial. Psychopharmacology (Berl). 2004;172:400-408. (Pubitemid 38650975)
46. Vink AC, Birks J, Bruinsma MS, et al. Music therapy for people with dementia. Cochrane Database Syst Rev. 2006. Art. No.: CD003477. DOI: 10.1002/14651858.CD003477.pub2
47. Lane-Brown AT, Tate RL. Apathy after acquired brain impairment: A systematic review of non-pharmacological interventions. Neuropsychol Rehabil. 2009;19:1-36.
48. Levy R, Dubois B. Apathy and functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex. 2006;16: 916-928. (Pubitemid 43992442)